Hypertension and Lifestyle Modifications

Kevin, you alluded to the sprint trial when discussing some of those high-risk patient groups. Could you expand a little bit about the demographics of that patient population and who that entails? Sure. So these patients were largely patients with chronic kidney disease who did not have diabetes and may have had some degree of protein area. Those excluded from the trial included those with glomerular phytus, polycystic kidney disease, greater than one gram of protein air per day or a very low GFR less than 20.